TherapeuticsMD Inc (TXMD)

[TechKim]

All things are possible. There is a May date that has not been reconfirmed.

Otherwise, even the true issues of discrepancies have yet to be disclosed in explicit detail. The bottom line is the product works. What the label and post marketing guidelines need to be to satisfy the FDA is the question. The high novelty of this product is that it deals with a sexual part of the body. Sex sells, even with label warnings.

The stock could shoot up on buy out rumours, or the stock could always find its way down below the assumed support level. Anything goes for the moment.